Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2024 Earnings Call Transcript February 27, 2025
Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $0.39, expectations were $0.1.
Operator: Good afternoon. My name is Darrell and I will be your conference call operator today. At this time, all participants are in a listen-only mode. After the speakers’ formal remarks, there will be a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded....
